Ratan Lab
Impact

You are here

Mithramycin is a gene-selective Sp1 inhibitor that identifies a biological intersection between cancer and neurodegeneration.

PUBLICATION: 
Journal Article
Authors: 
Sleiman SF, Langley BC, Basso M, Berlin J, Xia L, Payappilly JB, Kharel MK, Guo H, Marsh JL, Thompson LM, Mahishi L, Ahuja P, MacLellan WR, Geschwind DH, Coppola G, Rohr J, Ratan RR.
Year Published: 
2011
Publisher: 
J Neurosci. 2011 May 4;31(18):6858-70. doi: 10.1523/JNEUROSCI.0710-11.2011. Erratum in: J Neurosci. 2012 May 9;32(19):6743.
Identifiers: 
PMID:21543616 | PMCID:PMC3717375
Full-Text on PubMed

Associated

Research Methods